Skip to content
Solved
SearchBrowse
Sign in

Contents

Official guidance
Corporate Intangibles Research and Development Manual

CIRD75000 · VRR

  • CIRD75050 · Introduction
  • CIRD75100 · Vaccine Research Relief: Requirement that Company is a going concern
  • CIRD75200 · Qualifying expenditure: for an accounting period
  • CIRD75300 · Qualifying expenditure: on direct R&D
  • CIRD75400 · Qualifying expenditure: on sub-contracted R&D
  • CIRD75500 · Qualifying expenditure: on contributions to independent R&D
  • CIRD75525 · Subcontracting to charities, universities and scientific research organisations
  • CIRD75550 · Subcontracting to companies and others
  • CIRD75600 · How relief is given: SMEs
  • CIRD75700 · How relief is given: large companies
  • CIRD75800 · How relief is given: insurance companies
  • CIRD75900 · Inflated claims
  • CIRD75950 · Refunds of contributions and subcontract payments
  • CIRD76000 · Specified diseases: general
  • CIRD76100 · Specified diseases: tuberculosis and malaria
  • CIRD76200 · Specified diseases: HIV/AIDS
  • CIRD76300 · Definitions
  • CIRD76400 · Dealing with claims
  1. VRR: contents
  2. VRR: qualifying expenditure: on contributions to independent R&D

CIRD75500 | VRR: qualifying expenditure: on contributions to independent R&D

From HM Revenue & Customs · Corporate Intangibles Research and Development Manual

FA02/SCH13/PARA12

Section 27 of FA 2008 repealed paragraph 12 of Schedule 13 FA 2002 and as a result of this, expenditure incurred by companies on or after 1 August 2008 on contributions to independent R&D will no longer attract VRR.

Companies can of course make VRR claims in respect of expenditure incurred on or before 31 July 2008.

Relief is due if payments are made to:

  • a charity,

  • a university, or

  • a scientific research association,

for the purposes of funding qualifying R&D activity carried on by the body in question.

The R&D activity must be related to a trade carried on by the company CIRD75300. For example, a company that manufactures vaccine may give a contribution to a charity that is carrying out research into a new AIDS vaccine. If it does that, the company may claim VRR on the contribution.

There is a definition of charity in ICTA88/S506 (1) and scientific research organisation in ICTA88/S508 and those are the definitions that you should use. The effect of these is to restrict charities & scientific research organisations to bodies located in the UK. There is no similar restriction in the case of universities.

PreviousNext
PrivacyTerms